高血压的时间治疗的选择
1From the Department of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Cardiology in review
|March 20, 2024
概括
基于昼夜节律的计时药物或时间疗法显示出对高血压管理的前景. 虽然晚上剂量可能对一些患者更有效,但整体证据比较早晨和晚上剂量需要进一步研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 时间生物学 时间生物学
背景情况:
- 尽管有各种治疗策略,但对许多患者来说,血压控制仍然是一个挑战.
- 人们越来越认识到昼夜节律在高血压治疗中的作用.
- 目前的治疗模式在实现最佳血压控制方面存在局限性.
研究的目的:
- 探索长期治疗高血压的方法.
- 为了比较晚上和早上药物治疗降血压的有效性.
- 评估当前关于高血压慢性治疗的证据.
主要方法:
- 从2010年到2023年进行了Medline文献搜索.
- 关键词包括:血压控制,昼夜节律,早上药物管理,晚上药物管理.
- 选择和分析了38篇相关论文.
主要成果:
- 时间疗法是治疗高血压的有效方法.
- 晚上药物给药在特定情况下显示出更大的疗效,如早晨血压激增,夜间高血压和脏疾病.
- 没有发现晚上与上午的总体优势.
结论:
- 时间疗法是高血压治疗的可行选择.
- 需要进一步的研究来确定晚上与早上药物管理的最终益处.
- 考虑到昼夜模式的个性化方法可以改善血压管理.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
133
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
133
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Errors occurring during blood pressure monitoring
721
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
721
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
164
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
164


